Navigation Links
Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
Date:10/7/2009

FARMINGDALE, N.Y., Oct. 7 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Neurotechnics Ltd., based in Banbury, England, for the distribution of the BoneScalpel(TM) Ultrasonic Bone Cutter.

The agreement provides Neurotechnics with the rights to sell in the United Kingdom and the Republic of Ireland, and includes minimum purchase requirements.

Neurotechnics is recognized as an innovative market leader in the distribution of state-of-the-art medical devices and capital equipment, with special emphasis in neuro and spine surgery.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.

"Misonix welcomes Neurotechnics to our growing sales and distribution organization. Neurotechnics comes to us with an established reputation as a first tier distributor of advanced medical equipment in the United Kingdom and Ireland," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

    Investor Relations Contact:
    Kevin McGrath of Cameron Associates, Inc.
    212-245-4577
    Kevin@cameronassoc.com

SOURCE Misonix, Inc.


'/>"/>
SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 4, 2016 ... across 154 pages, profiling 09 key companies and ... a professional and in-depth study on the current ... basic overview of the industry including definitions, classifications, ... market analysis is provided for the international market ...
(Date:5/3/2016)... Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. Photo ... ... ... ... Sino-German High-Tech Fund (SGHF) is ...
(Date:5/3/2016)... OSWEGO, Ore. , May 3, 2016 /PRNewswire/ ... endovascular medical technology, today announced Food and Drug ... cardiac resynchronization defibrillator that provides heart failure patients ... scans. Iperia devices also have remote monitoring with ... that adapts the heart rate in response to ...
Breaking Medicine Technology:
(Date:5/4/2016)... Lake Charles, LA (PRWEB) , ... May 04, 2016 , ... ... Lake Charles, LA area has teamed up with Big Brothers Big Sisters of Southwest ... are now being accepted here . , Big Brothers Big Sisters of Southwest ...
(Date:5/4/2016)... ... ... Wellness Center today announced its tenth anniversary of providing a complete approach to health ... to provide a holistic approach to wellness has now become a growing trend of ... Chiropractic Physician , the wellness center offers a complete range of services such as ...
(Date:5/4/2016)... East Providence, Rhode Island (PRWEB) , ... May ... ... website was launched in April 2016. SS&A teamed up with one of the ... website. This legal information portal contains informative legal articles related to the law ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... that is transforming breastfeeding for nursing mothers. The company’s patented technology, The Smart ... breastfeeding. Today, the company announced that the technology is now available for purchase ...
(Date:5/4/2016)... Louis, MO (PRWEB) , ... May 04, 2016 , ... ... its newly launched health brand, Verywell, have tapped David Katz, MD, MPH, ... , “Our shared devotion to lifestyle medicine is especially gratifying,” said Katz. ...
Breaking Medicine News(10 mins):